» Articles » PMID: 39456927

Relationship Between C-Peptide Levels, Clinical Features, and Serum Data in a Brazilian Type 1 Diabetes Population with Large Variations in Genomic Ancestry

Abstract

Type 1 diabetes (T1D) is a chronic disease characterized by the immune-mediated destruction of the pancreatic beta cells responsible for insulin production. The secreted insulin and C-peptide are equimolar. Due to its longer half-life, C-peptide has become a safer means of assessing the pancreatic reserve. C-peptide levels were evaluated in a population of patients with T1D, focusing on the relationship between this variable and other factors. In addition, the influence of C-peptide on metabolic control and microvascular complications was investigated. This cross-sectional study included 95 patients who had been diagnosed with T1D at least five years earlier. These patients were evaluated using a clinical demographic survey, anthropometric data, laboratory tests, and fundoscopy. This study showed that 29.5% of patients had residual insulin secretion, which correlated directly with their age at diagnosis. No statistically significant differences in metabolic control or microvascular complications were observed between the C-peptide level groups. In addition, our results indicate that ancestry does not influence the persistence of residual C-peptide function in our highly mixed population. It is recommended that future research consider incorporating new variables, such as HLA and pancreatic autoimmunity, as factors that may influence residual β-cell function.

References
1.
Barker A, Lauria A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C . Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study. Diabetes Obes Metab. 2013; 16(3):262-7. DOI: 10.1111/dom.12216. View

2.
Kuhtreiber W, Washer S, Hsu E, Zhao M, Reinhold 3rd P, Burger D . Low levels of C-peptide have clinical significance for established Type 1 diabetes. Diabet Med. 2015; 32(10):1346-53. PMC: 4578991. DOI: 10.1111/dme.12850. View

3.
Pereira R, Phillips C, Pinto N, Santos C, Dos Santos S, Amorim A . Straightforward inference of ancestry and admixture proportions through ancestry-informative insertion deletion multiplexing. PLoS One. 2012; 7(1):e29684. PMC: 3260179. DOI: 10.1371/journal.pone.0029684. View

4.
Ilonen J, Lempainen J, Veijola R . The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. 2019; 15(11):635-650. DOI: 10.1038/s41574-019-0254-y. View

5.
Powers A . Type 1 diabetes mellitus: much progress, many opportunities. J Clin Invest. 2021; 131(8). PMC: 8262558. DOI: 10.1172/JCI142242. View